Site Mentor
Leader of Epidemiology and Biostatistics Unit, CIDEIM; Reader in Medical Statistics and Epidemiology, LSHTM
Colombia
Site Institution: Centro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM)
Research Focus: Vector-Borne And Emerging Infections (Leishmaniasis Malaria, Dengue), Mdr/Xdr Tb, Congenital And Secondary Syphilis, Hospital Associated Infections And Drug Resistance
Site Description:
Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) is a Colombian public-private non-profit organization dedicated to conducting biomedical research in infectious diseases. Research at CIDEIM includes multidisciplinary investigations of leishmaniasis; emerging infectious diseases, such as syphilis, dengue, and other arbovirus diseases transmitted by Aedes aegypti; drug-resistant malaria; MDR and XDR tuberculosis; and ecology and control of vectors for leishmaniasis, malaria, and dengue.
CIDEIM’s headquarters are in Cali, Colombia. In addition, a clinical research facility in Tumaco on the Pacific Coast. Training and research activities may be conducted in collaboration with partner institutions in Cali, including Universidad Icesi, Universidad del Valle, Hospital Universitario del Valle, and Fundación Valle del Lili.
CIDEIM investigators and faculty of the Yale School of Public Health have jointly conducted NIH-supported research and training since 2003. The longstanding CIDEIM/Yale collaboration includes a Fogarty Global Infectious Disease Training Program (Project No. 5D43TW006589), now in its fourth 5-year cycle. CIDEIM has hosted numerous students, trainees, and visiting scholars with support from a variety of sources, including the Yale Downs Fellowship, Fulbright, and Howard Hughes.
Other features of this site include:
- Biochemistry and Molecular Biology research laboratory to conduct proteomic and functional genomics research.
- Immunology and Cell Biology research laboratory has infrastructure to evaluate the immune response at the local, systemic and cellular level using technologies such as cytometric analysis of phenotypic and functional markers and leukocyte products and mediators, real time PCR of gene products and transcription factors, and ex vivo analysis of cells of the inflammatory and immune response.
- Microbiology and Molecular Diagnostics Laboratories have two biosafety level 2 (BSL-2) work areas. One BSL-2 is used to type and phenotypically characterize clinically-relevant microbial pathogens (bacteria and parasites), using conventional culture methods and PCR-based techniques. The second BSL-2 lab is primarily dedicated to molecular diagnosis and is equipped with qPCR technology, a BSC class II biosafety hood, and a four-module GeneXpert platform. The Microbiology Laboratory also has a BSL-3 workspace. These biosecurity features allow the culture and manipulation of aerosol transmissible pathogens such as Mycobacterium tuberculosis.
- Biostatistics and Epidemiology Research Unit collaborates with the other research units and investigators in the planning, execution, and analysis of research studies, with the overall aim of ensuring valid and insightful quantitative analytics.
- Clinical and Community Research Unit coordinates all recruitment, enrollment, and clinical management of participants for studies involving human subjects. It provides patient care for leishmaniasis and syphilis in CIDEIM. Other diagnostic services are provided in the field sites in Tumaco on the Pacific Coast and the municipalities of Rovira in Tolima and Pueblo Rico in Risaralda in the Andean region of Colombia. Importantly, the Clinical Unit has the support of infectious disease specialists from the Fundación Valle del Lili, a high complexity level 4 hospital, and Research Associate investigators who include dermatologist (Dr. Adriana Cruz), and pediatric infectious disease specialist (Dr. Eduardo Lopez) who provide support for the clinical management of complicated or unusual cases.
Mentors
U.S. Mentor
Professor of Epidemiology (Chronic Diseases) and Associate Dean for Diversity, Equity, Inclusion and Belonging; Director, Advanced Professional MPH Program; Track Director, Applied Analytic Methods and Epidemiology, Executive MPH; Affiliated Faculty, Yale Institute for Global Health; Core Faculty, National Clinician Scholars Program
Site Mentor
Professor Adjunct of Epidemiology (Microbial Diseases)
GHES Alumni
- Dr. Garcia Luna spent his fellowship year at the International Center for Medical Research and Training (CTDETM) in Cali under the mentorship of David Paltiel, PhD, Neal Alexander, PhD and Norman Maldonado, PhD. His research focused on the impact of transmission and cost-effectiveness of screening algorithms for syphilis in people living with HIV in Colombia and accurate screening algorithms that reduce time to treatment may impact on disease transmission by reducing the time a subject is infectious. Dr. Garcia is a physician and early career researcher who has been working on syphilis research since 2017 when he joined the Clinical and Community Research Unit of CTDETM as a clinical fellow. Tn 2020 he completed the MSc in Global Health Sciences and Epidemiology at the University of Oxford as part of an international Master's Fellowship awarded by the Wellcome Trust. His career goal is to contribute to decreasing the burden of sexuallytransmitted infections in Colombia through epidemiological research.